152 related articles for article (PubMed ID: 31700580)
1. Salivary Cytokines in patients with Head and Neck Cancer (HNC) treated with Radiotherapy.
Principe S; Dikova V; Bagán J
J Clin Exp Dent; 2019 Nov; 11(11):e1072-e1077. PubMed ID: 31700580
[TBL] [Abstract][Full Text] [Related]
2. Salivary IL-8 as a putative predictive biomarker of radiotherapy response in head and neck cancer patients.
Principe S; Zapater-Latorre E; Arribas L; Garcia-Miragall E; Bagan J
Clin Oral Investig; 2022 Jan; 26(1):437-448. PubMed ID: 34251535
[TBL] [Abstract][Full Text] [Related]
3. Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
Bossi P; Bergamini C; Miceli R; Cova A; Orlandi E; Resteghini C; Locati L; Alfieri S; Imbimbo M; Granata R; Mariani L; Iacovelli NA; Huber V; Cavallo A; Licitra L; Rivoltini L
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):959-966. PubMed ID: 27745982
[TBL] [Abstract][Full Text] [Related]
4. Is there difference in the comparative and quantitative salivary proteome between stimulated and unstimulated saliva in head and neck cancer patients treated by radiotherapy?
Ventura TMO; Santos PSS; Ribeiro NR; de Lima Leite A; Taira EA; Dionizio A; Rubira CMF; Buzalaf MAR
Oral Oncol; 2021 Jul; 118():105315. PubMed ID: 33985911
[TBL] [Abstract][Full Text] [Related]
5. Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies.
Citrin DE; Hitchcock YJ; Chung EJ; Frandsen J; Urick ME; Shield W; Gaffney D
Radiat Oncol; 2012 Apr; 7():64. PubMed ID: 22537315
[TBL] [Abstract][Full Text] [Related]
6. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy changes the salivary proteome in head and neck cancer patients: evaluation before, during, and after treatment.
Ventura TMO; Ribeiro NR; Taira EA; de Lima Leite A; Dionizio A; Rubira CMF; da Silva Santos PS; Buzalaf MAR
Clin Oral Investig; 2022 Jan; 26(1):225-258. PubMed ID: 34052889
[TBL] [Abstract][Full Text] [Related]
8. Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients.
Oton-Leite AF; Silva GB; Morais MO; Silva TA; Leles CR; Valadares MC; Pinezi JC; Batista AC; Mendonça EF
Lasers Surg Med; 2015 Apr; 47(4):296-305. PubMed ID: 25824475
[TBL] [Abstract][Full Text] [Related]
9. Role of Non-coding RNAs on the Radiotherapy Sensitivity and Resistance of Head and Neck Cancer: From Basic Research to Clinical Application.
Zhang X; Yang J
Front Cell Dev Biol; 2020; 8():637435. PubMed ID: 33644038
[TBL] [Abstract][Full Text] [Related]
10. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
11. Risk of CVD Following Radiotherapy for Head and Neck Cancer: An Updated Systematic Review and Meta-Analysis.
Lin PY; Cheng PC; Hsu WL; Lo WC; Hsieh CH; Shueng PW; Liao LJ
Front Oncol; 2022; 12():820808. PubMed ID: 35719982
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced cancer after radiotherapy for non-Hodgkin's lymphoma of the head and neck: a retrospective study.
Toda K; Shibuya H; Hayashi K; Ayukawa F
Radiat Oncol; 2009 Jul; 4():21. PubMed ID: 19591686
[TBL] [Abstract][Full Text] [Related]
13. The Association Between Computed Tomography-Defined Sarcopenia and Outcomes in Adult Patients Undergoing Radiotherapy of Curative Intent for Head and Neck Cancer: A Systematic Review.
Findlay M; White K; Lai M; Luo D; Bauer JD
J Acad Nutr Diet; 2020 Aug; 120(8):1330-1347.e8. PubMed ID: 32711854
[TBL] [Abstract][Full Text] [Related]
14. Curcumin treatment suppresses IKKβ kinase activity of salivary cells of patients with head and neck cancer: a pilot study.
Kim SG; Veena MS; Basak SK; Han E; Tajima T; Gjertson DW; Starr J; Eidelman O; Pollard HB; Srivastava M; Srivatsan ES; Wang MB
Clin Cancer Res; 2011 Sep; 17(18):5953-61. PubMed ID: 21821700
[TBL] [Abstract][Full Text] [Related]
15. Feasibility, SAR Distribution, and Clinical Outcome upon Reirradiation and Deep Hyperthermia Using the Hypercollar3D in Head and Neck Cancer Patients.
Kroesen M; van Holthe N; Sumser K; Chitu D; Vernhout R; Verduijn G; Franckena M; Hardillo J; van Rhoon G; Paulides M
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885258
[TBL] [Abstract][Full Text] [Related]
16. Salivary protein biomarkers for head and neck cancer.
Amenábar JM; Da Silva BM; Punyadeera C
Expert Rev Mol Diagn; 2020 Mar; 20(3):305-313. PubMed ID: 31986927
[No Abstract] [Full Text] [Related]
17. Study on the Salivary Microbial Alteration of Men With Head and Neck Cancer and Its Relationship With Symptoms in Southwest China.
Zuo HJ; Fu MR; Zhao HL; Du XW; Hu ZY; Zhao XY; Ji XQ; Feng XQ; Zhumajiang W; Zhou TH; Tian YL; Pei XF; Yu R; Hu XY
Front Cell Infect Microbiol; 2020; 10():514943. PubMed ID: 33244461
[TBL] [Abstract][Full Text] [Related]
18. Effect of Photobiomodulation on Salivary Cytokines in Head and Neck Cancer Patients with Oral Mucositis: A Systematic Review.
Khalil M; Hamadah O; Saifo M; Khalil H; Adi M; Alabeedi F; Kujan O
J Clin Med; 2024 May; 13(10):. PubMed ID: 38792366
[No Abstract] [Full Text] [Related]
19. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
[TBL] [Abstract][Full Text] [Related]
20. The relationship between TNF-α gene promoter polymorphism (- 1211 T > C), the plasma concentration of TNF-α, and risk of oral mucositis and shortening of overall survival in patients subjected to intensity-modulated radiation therapy due to head and neck cancer.
Mlak R; Powrózek T; Brzozowska A; Homa-Mlak I; Mazurek M; Gołębiowski P; Sobieszek G; Małecka-Massalska T
Support Care Cancer; 2020 Feb; 28(2):531-540. PubMed ID: 31076897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
